Valneva SE
World Rank (Jan-05-2024)
10,305
Market Cap (Jan-05-2024)
0.731 Billion USD
World Rank (Jul-30-2023)
8,149
Market Cap (Jul-30-2023)
1.127 Billion USD
World Rank (Dec-25-2022)
8,412
Market Cap (Dec-25-2022)
0.989 Billion USD
World Rank (Jan-07-2022)
6,098
Market Cap (Jan-07-2022)
2.10 Billion USD
Annual Revenue in USD
398 Million USD
Annual Net Income in USD
-158 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Valneva SE is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company annual revenue is 110.3 million EUR and total assets are 449 million EUR as on 2020. The headquarters is in France.
Company Website
Wikipedia